Amphioxus Cell Technologies Company Profile

07:30 EST 16th December 2018 | BioPortfolio

Amphioxus Cell Technologies is a biotechnology company based in Houston, Texas.The Company was founded by James Kelly and Norman Sussman to develop human liver based ADME/Tox tools. Our ACTIVTox® product achieves this goal by combining a highly developed human liver cell line with meaningful, high throughput assays.


11222 Richmond Ave., Suite 180
United States of America


Phone: 281.679.7900
Fax: 281.679.7910

News Articles [1477 Associated News Articles listed on BioPortfolio]

Amphioxus functional genomics and the origins of vertebrate gene regulation

Stem Cell Sciences: Stem Cell Technologies: The End of the Beginning

In this exclusive interview, Fintan Walton talks to Peter Mountford, formerly CEO of Stem Cell Sciences, about the current state of stem cell technologies and their potential healthcare and research a...

Living Cell Technologies: New Technologies and Clinical Trials

In this episode of PharmaTelevision News Review, Fintan Walton talks with Dr Paul Tan, CEO of Living Cell Technologies. Filmed at AusBiotech 2009, they discuss: • The company’s origins and aims ...

The ancient history of DNA control

One of the lead authors on the study, published in the journal Nature, was Dr Ozren Bogdanovic, from Sydney’s Garvan Institute of Medical Research. He described DNA as “a powerful code”, with sp...

Shanghai Cell Therapy Closes $40 Million C1 Round for Cancer Drugs

Shanghai Cell Therapy completed a $40 million Series C1 financing, led by China Industrial Asset Management, which contributed $26 million of the total. Shanghai Cell Therapy is developing oncology dr...

NYSCF partners with TOOLGEN, NSAGE to integrate gene editing and stem cell technologies

(New York Stem Cell Foundation) The New York Stem Cell Foundation (NYSCF) Research Institute today announced a strategic partnership with Korean firms ToolGen, Inc., and nSAGE, Inc.. In a Memorandum o...

Pig Cell Potential, PTV News: Feb 15, 2010

A revolutionary treatment for type 1 diabetes. We interview Paul Tan, the CEO of Living Cell Technologies.[Feb 15, 16:10 GMT]

Karolinska University Hospital And GE Healthcare Collaborate To Advance Technologies For Cell Therapy

Karolinska University Hospital Sweden and GE Healthcare Life Sciences recently announced a joint research collaboration to drive advances in technologies and workflows for use in the rapidly emerging ...

PubMed Articles [3047 Associated PubMed Articles listed on BioPortfolio]

Functional characterization of thyrostimulin in amphioxus suggests an ancestral origin of the TH signaling pathway.

Thyrostimulin, consisting of GpA2 and GpB5 subunits, has been identified in amphioxus, but to date, little is known about the roles of GPA2/GPB5-type hormone in this evolutionarily important animal. W...

Using Amphioxus as a Basal Chordate Model to Study BMP Signaling Pathway.

The BMP signaling pathway has been shown to be involved in different aspects of embryonic development across diverse metazoan phyla. Comparative studies on the roles of the BMP signaling pathway provi...

Characterisation of amphioxus protein kinase C-δ/θ reveals a unique proto-V3 domain suggesting an evolutionary mechanism for PKC-θ unique V3.

A primitive adaptive immune system has recently been suggested to be present in a basal chordate amphioxus (Branchiostoma belcheri, Bb), making it an ideal model for studying the origin of adaptive im...

Genome-wide transcriptional response of microRNAs to the benzo(a)pyrene stress in amphioxus Branchiostoma belcheri.

Amphioxus, a cephalochordate found in sand habitats in shallow in-shore seawaters, has been widely used as a model in comparative immunology of chordates. However, the role of microRNAs (miRNAs) in am...

Integrative analysis of single-cell expression data reveals distinct regulatory states in bidirectional promoters.

Bidirectional promoters (BPs) are prevalent in eukaryotic genomes. However, it is poorly understood how the cell integrates different epigenomic information, such as transcription factor (TF) binding ...

Clinical Trials [6924 Associated Clinical Trials listed on BioPortfolio]

Establishment of Comprehensive Genetic Analysis From a Single Cell

Preimplantation genetic diagnosis (PGD) is the integration of both assisted reproductive technologies and molecular genetic technologies and was shown to improve implantation rate and redu...

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Companies [2273 Associated Companies listed on BioPortfolio]

Amphioxus Cell Technologies

Amphioxus Cell Technologies is a biotechnology company based in Houston, Texas.The Company was founded by James Kelly and Norman Sussman to develop human liver based ADME/Tox tools. Our ACTIVTox® pro...

ReNeuron Group plc

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our ste...

Guava Technologies, Inc

Guava Technologies is a private biotechnology and medical device company that designs and manufactures easy-to-use, on-demand, benchtop cell analysis systems. The company has ISO13485 certificati...

MEDINET Co., Ltd. and MaxCyte, Inc.

MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technol...

AVIVA Biosciences Corporation

AVIVA Biosciences CorpBased in San Diego, CA., AVIVA Biosciences Corporation develops enabling drug discovery and development technologies by combining biochips with cell biology. Key application area...

More Information about "Amphioxus Cell Technologies" on BioPortfolio

We have published hundreds of Amphioxus Cell Technologies news stories on BioPortfolio along with dozens of Amphioxus Cell Technologies Clinical Trials and PubMed Articles about Amphioxus Cell Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Amphioxus Cell Technologies Companies in our database. You can also find out about relevant Amphioxus Cell Technologies Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Corporate Database Quicklinks

Searches Linking to this Company Record